Le Lézard
Classified in: Business
Subject: ATY

(SAVA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Cassava Class Action Lawsuit


SAN DIEGO, Oct. 16, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA). The class action is on behalf of shareholders who purchased Generac common stock between September 14, 2020 and August 27, 2021. If you wish to serve as lead plaintiff in this class action, you must move the Court no later than October 26, 2021.

[click here to join this action]

According to the filed complaint: (a) the quality and integrity of the scientific data supporting Cassava's claims for simufilam's, a small molecule drug designed to treat Alzheimer's disease, efficacy had been overstated; (b) the scientific data supporting Cassava's claims for simufilam's efficacy were biased; and (c) as a result of the foregoing, Defendants' positive statements during the Class Period about the Company's business metrics and financial prospects and the likelihood of Food and Drug Administration approval were false and misleading and lacked a reasonable basis.

A lead plaintiff will act on behalf of all other class members in directing the Cassava class-action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the class-action lawsuit. An investor's ability to share any potential future recovery of the Cassava class action lawsuit is not dependent upon serving as lead plaintiff.

If you suffered a substantial loss and are interested in learning more about being a lead plaintiff, please contact Jim Baker (jimb@johnsonfistel.com) by email or phone at 619-814-4471. If emailing, please include a phone number. Additionally, you can [click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com

[click here to join this action]

SOURCE Johnson Fistel, LLP


These press releases may also interest you

at 02:09
Dubai-based delivery company iMile founder and CEO Rita Huang, formerly of Alibaba and Huawei, today announced a $40 Million Series A financing round at a 350 million US dollar valuation. This is the largest series A round by a woman in the region...

at 02:00
Galantas Gold Corporation ("Galantas" or the "Company") is pleased to announce its unaudited financial results for the quarter ended September 30, 2021. Financial Highlights Highlights of the third quarter 2021 results are summarized below. All...

at 02:00
For immediate release 30 November 2021   Serabi Gold plc ("Serabi" or the "Company") Unaudited interim results for the third quarter and nine month period ended 30 September 2021   Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian focused gold...

at 02:00
Industry-leading audio brand, Tronsmart, is pleased to announce the launch of the ONYX PRIME True Wireless Earbuds. The latest addition to the innovative audio collection, the ONYX PRIME offer an exceptional listening experience thanks to the...

at 02:00
DPS Group, a privately-owned, global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, is expanding its European operations with the establishment of a new office in Switzerland to...

at 02:00
SERB and BTG Specialty Pharmaceuticals today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending a marketing authorisation for Voraxaze®...



News published on 16 october 2021 at 01:00 and distributed by: